EC approves Velcade for multiple myeloma treatment
A single license has been granted to market Velcade in the 15 member states of the EU, plus Norway and Iceland. In addition it will ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
